Yunyun Xiong | World Stroke Organization
Yunyun  Xiong

Yunyun Xiong


Member Bio

Yunyun Xiong, M.D.,Ph.D., is a chief physician and associate professor, deputy head of Division of Vascular Neurology, Department of Neurology, Beijing Tiantan Hospital. She received her M.D.from Fudan University in 2006, and was trained as a fellow in Huashan Hospital affiliated to Fudan University in Shanghai in 2008. Then she received her Ph.D. degree from the Chinese University of Hong Kong in 2011, and subsequent Postdoctoral fellowship in 2012. She was trained as a research fellow on acute reperfusion therapy and artificial intelligence in BIDMC, Harvard Medical School from 05/2018 to 08/2019.

Her research focuses on reperfusion therapy and artificial intelligence in acute ischemic stroke. She has published 84 peer-reviewed SCI papers, with featured articles published on Circulation research, Stroke, JNNP etc, and received 3 NSFC grants in China.  She is the co-PI for the first retrospective multicenter thrombectomy registry in China (The endovascular treatment for acute anterior circulation ischemic stroke registry [ACTUAL]), and was responsible for the study design of Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST) trial and the ongoing Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events Ⅲ (TRACE Ⅲ, NCT05141305). 

She has broad stroke networks in China, with close collaborations with more than 100 comprehensive stroke centers that are capable for thrombolysis and endovascular treatment. Besides, she is very active with international collaborations. She used to take part in the Vitamins to prevent stroke (VITATOPS) trial MRI substudy in Hong Kong,  the small vessel disease epidemiology study among China, Hong Kong and Australia, and joined in the WSO BEAT program.

Our partners and sponsors

Achieving our vision of a life free from stroke is a task that WSO cannot achieve alone. We are committed to building our partnerships at the global, regional and national level to scale up and deliver improvements in prevention, treatment and support to reduce the burden of stroke.

Medtronic Platinum Plus
Boehringer Ingelheim Platinum Plus
BMS Pfizer Gold
Allm Bronze